MX343251B - Biomarcador. - Google Patents
Biomarcador.Info
- Publication number
- MX343251B MX343251B MX2011006773A MX2011006773A MX343251B MX 343251 B MX343251 B MX 343251B MX 2011006773 A MX2011006773 A MX 2011006773A MX 2011006773 A MX2011006773 A MX 2011006773A MX 343251 B MX343251 B MX 343251B
- Authority
- MX
- Mexico
- Prior art keywords
- acid sequence
- biomarkers
- lung cancer
- biomarker
- bladder cancer
- Prior art date
Links
- 239000000090 biomarker Substances 0.000 title abstract 4
- 108700005856 engrailed 2 Proteins 0.000 abstract 3
- 206010005003 Bladder cancer Diseases 0.000 abstract 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract 2
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 abstract 2
- 201000005202 lung cancer Diseases 0.000 abstract 2
- 208000020816 lung neoplasm Diseases 0.000 abstract 2
- 201000005112 urinary bladder cancer Diseases 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000003384 imaging method Methods 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0823445.2A GB0823445D0 (en) | 2008-12-23 | 2008-12-23 | Biomarker |
| PCT/GB2009/002926 WO2010073001A1 (en) | 2008-12-23 | 2009-12-21 | Biomarker |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2011006773A MX2011006773A (es) | 2011-08-03 |
| MX343251B true MX343251B (es) | 2016-10-31 |
Family
ID=40344114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2011006773A MX343251B (es) | 2008-12-23 | 2009-12-21 | Biomarcador. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9624548B2 (https=) |
| EP (1) | EP2382327B1 (https=) |
| JP (1) | JP5947040B2 (https=) |
| CN (1) | CN102301006B (https=) |
| AU (1) | AU2009332712B2 (https=) |
| BR (1) | BRPI0923525A2 (https=) |
| CA (1) | CA2747760C (https=) |
| ES (1) | ES2725150T3 (https=) |
| GB (1) | GB0823445D0 (https=) |
| IL (1) | IL213510A (https=) |
| MX (1) | MX343251B (https=) |
| NZ (1) | NZ593392A (https=) |
| RU (1) | RU2573925C2 (https=) |
| WO (1) | WO2010073001A1 (https=) |
| ZA (1) | ZA201105184B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2472856B (en) | 2009-08-21 | 2012-07-11 | Cantargia Ab | IL1-RAP modulators and uses thereof |
| US9403906B2 (en) * | 2011-01-19 | 2016-08-02 | Cantargia Ab | Method of treatment of a solid tumor with interleukin-1 accessory protein antibody |
| US11371941B2 (en) * | 2016-07-04 | 2022-06-28 | Celltool Gmbh | Device and method for the determination of transfection |
| KR101777085B1 (ko) * | 2017-02-23 | 2017-09-11 | 주식회사 성균바이오텍 | En2 단백질의 면역원성 단편 펩타이드 또는 이를 특이적으로 인식하는 항체 조성물 |
| KR101923199B1 (ko) | 2018-04-25 | 2018-11-28 | 주식회사 무진메디 | 펩스타틴 a를 함유하는 소변 내 en2 진단용 조성물 |
| US20220389514A1 (en) | 2019-10-02 | 2022-12-08 | Kyushu University, National University Corporation | Biomarker, method, kit and array for predicting therapeutic effects of bcg intravesical infusion therapy in treating bladder cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2469089A1 (en) | 2003-07-08 | 2005-01-08 | Institut De Recherches Cliniques De Montreal | En-2 gene, disgnostic and therapeutic uses thereof |
| CN101175862A (zh) * | 2005-02-10 | 2008-05-07 | 肿瘤疗法科学股份有限公司 | 诊断膀胱癌的方法 |
| GB0625321D0 (en) * | 2006-12-19 | 2007-01-24 | Univ Surrey | Cancer biomarker |
| WO2008087040A2 (en) * | 2007-01-19 | 2008-07-24 | Epigenomics Ag | Methods and nucleic acids for analyses of cell proliferative disorders |
| CA2708163A1 (en) | 2007-12-11 | 2009-06-18 | Epigenomics Ag | Methods and nucleic acids for analyses of cell proliferative disorders |
-
2008
- 2008-12-23 GB GBGB0823445.2A patent/GB0823445D0/en not_active Ceased
-
2009
- 2009-12-21 EP EP09805934.8A patent/EP2382327B1/en not_active Not-in-force
- 2009-12-21 AU AU2009332712A patent/AU2009332712B2/en not_active Ceased
- 2009-12-21 RU RU2011130795/10A patent/RU2573925C2/ru not_active IP Right Cessation
- 2009-12-21 JP JP2011541583A patent/JP5947040B2/ja not_active Expired - Fee Related
- 2009-12-21 NZ NZ593392A patent/NZ593392A/xx not_active IP Right Cessation
- 2009-12-21 BR BRPI0923525-6A patent/BRPI0923525A2/pt not_active Application Discontinuation
- 2009-12-21 WO PCT/GB2009/002926 patent/WO2010073001A1/en not_active Ceased
- 2009-12-21 CA CA2747760A patent/CA2747760C/en active Active
- 2009-12-21 US US13/141,787 patent/US9624548B2/en active Active
- 2009-12-21 ES ES09805934T patent/ES2725150T3/es active Active
- 2009-12-21 MX MX2011006773A patent/MX343251B/es active IP Right Grant
- 2009-12-21 CN CN200980155785.7A patent/CN102301006B/zh not_active Expired - Fee Related
-
2011
- 2011-06-13 IL IL213510A patent/IL213510A/en active IP Right Grant
- 2011-07-14 ZA ZA2011/05184A patent/ZA201105184B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009332712A1 (en) | 2011-07-07 |
| US20120020888A1 (en) | 2012-01-26 |
| IL213510A0 (en) | 2011-07-31 |
| CN102301006A (zh) | 2011-12-28 |
| NZ593392A (en) | 2013-05-31 |
| CA2747760C (en) | 2020-01-21 |
| EP2382327A1 (en) | 2011-11-02 |
| RU2011130795A (ru) | 2013-01-27 |
| ES2725150T3 (es) | 2019-09-19 |
| IL213510A (en) | 2016-04-21 |
| EP2382327B1 (en) | 2019-02-13 |
| US9624548B2 (en) | 2017-04-18 |
| JP5947040B2 (ja) | 2016-07-06 |
| AU2009332712B2 (en) | 2015-05-28 |
| JP2012513584A (ja) | 2012-06-14 |
| CA2747760A1 (en) | 2010-07-01 |
| CN102301006B (zh) | 2015-07-15 |
| ZA201105184B (en) | 2012-02-29 |
| GB0823445D0 (en) | 2009-01-28 |
| RU2573925C2 (ru) | 2016-01-27 |
| MX2011006773A (es) | 2011-08-03 |
| WO2010073001A1 (en) | 2010-07-01 |
| BRPI0923525A2 (pt) | 2020-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN04381A (https=) | ||
| EP2527466A3 (en) | Genetic variants on CHR2 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment | |
| ATE527385T1 (de) | Mit tumoren assoziierte genetische variationen | |
| MX2011006773A (es) | Biomarcador. | |
| WO2009153775A3 (en) | Methods for distinguishing between specific types of lung cancers | |
| WO2010019921A3 (en) | Biomarkers for diagnosis and treatment of chronic lymphocytic leukemia | |
| WO2011015944A3 (en) | Use of free dna as an early predictor of severity in acute pancreatitis | |
| WO2007041245A3 (en) | Biomarkers for multiple sclerosis and methods of use thereof | |
| EP2611941A4 (en) | GENESIS OF CANCER DIAGNOSIS AND PROGNOSIS | |
| WO2011073629A3 (en) | Cancer diagnosis and treatment | |
| WO2009094647A3 (en) | P53 biomarkers | |
| IL190796A (en) | Composition containing nucleic acid encoded by anti-osteoclastogenic protein | |
| ATE551073T1 (de) | Markierte hgf-bindende peptide für bildgebung | |
| WO2008073899A3 (en) | Prrg4-associated compositions and methods of use thereof in methods of tumor diagnosis | |
| WO2006110599A3 (en) | Cacna1e in cancer diagnosis, detection and treatment | |
| WO2010004590A3 (en) | Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment | |
| WO2011106541A3 (en) | Diagnostic methods involving loss of heterozygosity | |
| WO2009150255A3 (en) | Markers for predicting response and survival in anti-egfr treated patients | |
| WO2008103971A3 (en) | Prostate cancer survival and recurrence | |
| WO2010028373A3 (en) | Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patients | |
| WO2009074328A8 (en) | Methods and nucleic acids for analyses of lung carcinoma | |
| WO2010132370A3 (en) | Soluble tlt-1 for the treatment and diagnosis of sepsis | |
| WO2009087462A3 (en) | Ephrin type-a receptor 10 protein | |
| WO2017027391A3 (en) | Genetic abnormalities in plasma cell dyscrasias | |
| WO2006110594A3 (en) | Sema4d in cancer diagnosis, detection and treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |